Tong X et al. |
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15063780
|
Kurtev V et al. |
Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. |
2004 |
J. Biol. Chem. |
pmid:15140878
|
Kim YH et al. |
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. |
2004 |
Carcinogenesis |
pmid:15142888
|
Klampfer L et al. |
Requirement of histone deacetylase activity for signaling by STAT1. |
2004 |
J. Biol. Chem. |
pmid:15123634
|
Fu M et al. |
The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. |
2004 |
J. Biol. Chem. |
pmid:15123687
|
Phan D et al. |
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. |
2004 |
Cancer Res. |
pmid:15126343
|
Iezzi S et al. |
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. |
2004 |
Dev. Cell |
pmid:15130492
|
Lemonde S et al. |
Cell type-dependent recruitment of trichostatin A-sensitive repression of the human 5-HT1A receptor gene. |
2004 |
J. Neurochem. |
pmid:14756806
|
Hattori N et al. |
Epigenetic control of mouse Oct-4 gene expression in embryonic stem cells and trophoblast stem cells. |
2004 |
J. Biol. Chem. |
pmid:14761969
|
Christian M et al. |
Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140. |
2004 |
J. Biol. Chem. |
pmid:14736873
|
Nishikawa J et al. |
Upregulation of LMP1 expression by histone deacetylase inhibitors in an EBV carrying NPC cell line. |
2004 |
Virus Genes |
pmid:14739656
|
Milhem M et al. |
Modification of hematopoietic stem cell fate by 5aza 2'deoxycytidine and trichostatin A. |
2004 |
Blood |
pmid:14976039
|
Wang DF et al. |
QSAR studies of PC-3 cell line inhibition activity of TSA and SAHA-like hydroxamic acids. |
2004 |
Bioorg. Med. Chem. Lett. |
pmid:14741273
|
Agostinho M et al. |
Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis. |
2004 |
Mol. Biol. Cell |
pmid:14978217
|
Sakata R et al. |
Trichostatin A activates the osteopontin gene promoter through AP1 site. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14985105
|
Knobbe CB et al. |
Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. |
2004 |
J. Natl. Cancer Inst. |
pmid:15026474
|
Chung YL et al. |
Antitumor histone deacetylase inhibitors suppress cutaneous radiation syndrome: Implications for increasing therapeutic gain in cancer radiotherapy. |
2004 |
Mol. Cancer Ther. |
pmid:15026552
|
Steiner E et al. |
SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15047174
|
Kypreou KP et al. |
Age-dependent response of lymphocytes in the induction of the linker histone variant, H1 degrees and histone H4 acetylation after treatment with the histone deacetylase inhibitor, trichostatin A. |
2004 |
Exp. Gerontol. |
pmid:15050280
|
Nan X et al. |
Potent stimulation of gene expression by histone deacetylase inhibitors on transiently transfected DNA. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15465025
|
Lee HS et al. |
Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray. |
2004 |
Biol. Pharm. Bull. |
pmid:15467184
|
Sangster-Guity N et al. |
Molecular profiling of embryonal carcinoma cells following retinoic acid or histone deacetylase inhibitor treatment. |
2004 |
Cancer Biol. Ther. |
pmid:15467438
|
Alcendor RR et al. |
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. |
2004 |
Circ. Res. |
pmid:15486319
|
Gius D et al. |
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. |
2004 |
Cancer Cell |
pmid:15488759
|
De La Fuente R et al. |
Major chromatin remodeling in the germinal vesicle (GV) of mammalian oocytes is dispensable for global transcriptional silencing but required for centromeric heterochromatin function. |
2004 |
Dev. Biol. |
pmid:15501230
|
Lin AC et al. |
The N termini of Friend of GATA (FOG) proteins define a novel transcriptional repression motif and a superfamily of transcriptional repressors. |
2004 |
J. Biol. Chem. |
pmid:15507435
|
GarcÃa I et al. |
Chromatin rearrangements in the prnD-prnB bidirectional promoter: dependence on transcription factors. |
2004 |
Eukaryotic Cell |
pmid:14871945
|
Takai N et al. |
Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. |
2004 |
Clin. Cancer Res. |
pmid:14871994
|
Ishiguro K and Sartorelli AC |
Activation of transiently transfected reporter genes in 3T3 Swiss cells by the inducers of differentiation/apoptosis--dimethylsulfoxide, hexamethylene bisacetamide and trichostatin A. |
2004 |
Eur. J. Biochem. |
pmid:15182353
|
Brieger A et al. |
In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors. |
2004 |
Biochem. Pharmacol. |
pmid:15183120
|
Shim JS et al. |
Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells. |
2004 |
Oncogene |
pmid:14661058
|
Boehrer S et al. |
In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis. |
2004 |
Leuk. Lymphoma |
pmid:15359646
|
Vaghefi H and Neet KE |
Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. |
2004 |
Oncogene |
pmid:15361854
|
Moore PS et al. |
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. |
2004 |
Biochim. Biophys. Acta |
pmid:15363630
|
Chiba T et al. |
Identification of genes up-regulated by histone deacetylase inhibition with cDNA microarray and exploration of epigenetic alterations on hepatoma cells. |
2004 |
J. Hepatol. |
pmid:15336447
|
Liu CJ et al. |
Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. |
2004 |
J. Biol. Chem. |
pmid:15337766
|
Cosio BG et al. |
Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. |
2004 |
J. Exp. Med. |
pmid:15337792
|
Iijima K et al. |
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid. |
2004 |
Leuk. Lymphoma |
pmid:15291362
|
Tóth KF et al. |
Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. |
2004 |
J. Cell. Sci. |
pmid:15292402
|
Marengo E et al. |
Identification of the regulatory proteins in human pancreatic cancers treated with Trichostatin A by 2D-PAGE maps and multivariate statistical analysis. |
2004 |
Anal Bioanal Chem |
pmid:15257427
|
Schauber J et al. |
Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. |
2004 |
Mol. Immunol. |
pmid:15261456
|
De La Fuente R et al. |
ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. |
2004 |
Dev. Biol. |
pmid:15242786
|
Fang JY et al. |
Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: Colo-320 and SW1116. |
2004 |
Cell Res. |
pmid:15225415
|
Banwell CM et al. |
Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. |
2004 |
J. Steroid Biochem. Mol. Biol. |
pmid:15225779
|
Mao DY et al. |
Promoter-binding and repression of PDGFRB by c-Myc are separable activities. |
2004 |
Nucleic Acids Res. |
pmid:15226411
|
Naruse Y et al. |
Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation. |
2004 |
Mol. Cell. Biol. |
pmid:15226430
|
Alao JP et al. |
Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines. |
2004 |
Clin. Cancer Res. |
pmid:15585645
|
Chen WK et al. |
[Effect of trichostatin A on histone acetylation level and apoptosis in HL-60 cells]. |
2004 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15228659
|
Kim JH et al. |
Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitor. |
2004 |
Int. J. Radiat. Oncol. Biol. Phys. |
pmid:15234053
|
Sakamoto S et al. |
Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. |
2004 |
J. Biol. Chem. |
pmid:15194680
|